Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6UEF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $11,345
Award facts
- Contract value 100% obligated
- $11,344.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,344.96 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count packages). This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical supply vehicle that extends through December 2026 and serves as the primary mechanism for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for medical procurement across the Department of Defense and related healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to supply a comprehensive range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for Otezla, a treatment medication commonly used in dermatology and rheumatology, exemplifies the routine pharmaceutical supply operations conducted under the company's prime vendor agreement and reflects the ongoing operational needs of military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DX25F6UEF?
SPE2DX25F6UEF was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 2, 2025.
How much is contract SPE2DX25F6UEF worth?
The government has obligated $11,345 on SPE2DX25F6UEF.
Is contract SPE2DX25F6UEF an order under another contract?
Yes. SPE2DX25F6UEF is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6UEF competed?
The extent of competition for SPE2DX25F6UEF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award